Genomics company changing patient care through molecular diagnostics and the Molecular Microscope® (MMDx®) service.
Edmonton, Alberta
Joined April 2016
- Tweets212
- Following229
- Followers117
- Likes139
New in @AmJTransplant: Bronchial mucosal biopsies may offer a safer way to diagnose T cell-mediated rejection after lung transplant. Molecular results closely matched transbronchial biopsies (AUC 0.99), and TCMR predicted CLAD and graft loss. sciencedirect.com/science/ar…
Kashi Clinical Laboratories invests in TSI to strengthen collaboration and accelerate advancements in MMDx research to support discovery of mechanisms, clinical trials, and clinical decision-making to improve patient outcomes. More: kashilab.com/blog/kashi-inve…
New in @jclinicalinvest: Digital cytometry across 10,000+ kidney, heart, lung & liver transplant biopsies reveals shared immune-cell signatures linked to rejection, advancing gene-expression monitoring and treatment tracking. jci.org/articles/view/208686
#MMDx #TransplantResearch
TranscriptomeSciInc retweeted
In Trifecta-Heart, #HeartTransplant ABMR was ~50% DSA-negative. While DSA-negative molecular ABMR was slightly earlier and less intense than DSA-positive ABMR, dd-cfDNA and molecular features were the same. @TranscriptomeSI
🔗: jhltonline.org/article/S1053…
